ReviewJournal of fish diseases2026
A Review of Nonsteroidal Anti-Inflammatory Drugs for Food-Producing Animals With a Focus on Potential Applications for Farmed Finfish.
Review in Journal of fish diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In finfish aquaculture, there are several inflammatory diseases impacting productivity and animal welfare, however there are limited options available to veterinarians to treat inflammation and pain in fish. Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in terrestrial animals raised for human consumption to treat a range of diseases and to manage pre- and postoperative pain as they offer anti-inflammatory, antipyretic and analgesic properties. This review examines the use of NSAIDs in terrestrial food animals with the pharmacological and safety learnings to the possible use in aquaculture, specifically for oral administration of farmed salmonids. Across Norway, United Kingdom and Australia, which are salmon producing regions burdened by inflammatory disorders such as complex gill disease, seven NSAIDs are authorised for use in terrestrial food-producing animals. The NSAIDs considered in this review have a good safety profile for users and the targeted terrestrial animal species, but more research is needed to develop safe and effective treatment regimens for farmed fish. Some NSAIDs have been shown to reduce pain sensitivity in fish but there is no published data demonstrating that they reduce inflammation. However, the targeted immune pathways of NSAIDs appear conserved between fish and terrestrial animals so it is highly likely that NSAIDs will have anti-inflammatory effects in fish if they can be delivered effectively through in-feed treatments. This review informs prescribing fish veterinarians and fish health professionals, as well as researchers, national licensing authorities and other stakeholders, to assist with consideration of the use and potential applications of the NSAIDs in finfish aquaculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.